Enterprise Value

114.7M

Cash

119.8M

Avg Qtr Burn

-420.5K

Short % of Float

7.33%

Insider Ownership

1.80%

Institutional Own.

99.81%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date